— Published date: 2/17/2026
Value Proposition: Novel method that measures levels of Alzheimer’s disease-related biomarkers to improve patient care and satisfaction for cochlear implant outcomes.
Technology Description
Researchers at Washington University in St. Louis have developed a method…
— Published date: 1/16/2026
Value Proposition: Novel antithromboinflammatory therapeutic that utilizes humanized antibodies to prevent and attenuate thromboinflammatory diseases, including arterial thrombosis, ischemic stroke, and vascular inflammation.
Technology Description
Researchers at Wash…
— Published Date: 5/14/2025
Value Proposition: Novel antisense oligonucleotide (ASO) directly targeting a microRNA-mediated mechanism responsible for autophagy reduction and neurodegeneration in Huntington’s disease (HD) improving patient outcomes in pre-HD subjects.
Technology Description
R…
— Published Date: 5/15/2025
Value proposition: Novel analgesic compounds that block CaV3.2 currents in nociceptive dorsal root ganglion neurons in order preemptively treat pain in subjects, unlike other products that are continuously administered post onset of pain.
Technology Description
Resear…
— Published Date: 5/14/2025
Value proposition: Novel ASOs that increase key protein production to limit neurodegeneration caused by ALS and frontotemporal dementia (FTD).
Technology Description
TDP-43 pathology is present in ~97% of ALS, ~50% of FTD, and frequently observed in other neurodegenerat…
| Name | # Summaries | Author |
|---|---|---|
| 15 | ||
| 13 | ||
| 15 | ||
| 26 | ||
| 14 | ||
| 14 |
Creating...
